Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population A Koliada, G Syzenko, V Moseiko, L Budovska, K Puchkov, V Perederiy, ... BMC microbiology 17, 1-6, 2017 | 982 | 2017 |
Gut microbiota: A player in aging and a target for anti-aging intervention AM Vaiserman, AK Koliada, F Marotta Ageing research reviews 35, 36-45, 2017 | 452 | 2017 |
Telomere length as a marker of biological age: state-of-the-art, open issues, and future perspectives A Vaiserman, D Krasnienkov Frontiers in genetics 11, 630186, 2021 | 314 | 2021 |
Health impacts of low-dose ionizing radiation: current scientific debates and regulatory issues A Vaiserman, A Koliada, O Zabuga, Y Socol Dose-Response 16 (3), 1559325818796331, 2018 | 229 | 2018 |
Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932–33: a retrospective cohort study LH Lumey, MD Khalangot, AM Vaiserman The lancet Diabetes & endocrinology 3 (10), 787-794, 2015 | 202 | 2015 |
Epigenetic programming by early‐life stress: Evidence from human populations AM Vaiserman Developmental Dynamics 244 (3), 254-265, 2015 | 177 | 2015 |
Nanodelivery of natural antioxidants: an anti-aging perspective A Vaiserman, A Koliada, A Zayachkivska, O Lushchak Frontiers in bioengineering and biotechnology 7, 447, 2020 | 166 | 2020 |
Early-life exposure to endocrine disrupting chemicals and later-life health outcomes: an epigenetic bridge? A Vaiserman Aging and disease 5 (6), 419, 2014 | 160 | 2014 |
Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population A Vaiserman, M Romanenko, L Piven, V Moseiko, O Lushchak, ... BMC microbiology 20, 1-8, 2020 | 155 | 2020 |
Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment AM Vaiserman Dose-Response 8 (2), dose-response. 09-037. Vaiserman, 2010 | 150 | 2010 |
Anti-aging pharmacology: promises and pitfalls AM Vaiserman, V Lushchak, AK Koliada Ageing research reviews 31, 9-35, 2016 | 138 | 2016 |
Hormesis and epigenetics: is there a link? AM Vaiserman Ageing research reviews 10 (4), 413-421, 2011 | 118 | 2011 |
Metformin as a geroprotector: experimental and clinical evidence V Piskovatska, N Stefanyshyn, KB Storey, AM Vaiserman, O Lushchak Biogerontology 20, 33-48, 2019 | 113 | 2019 |
Fucoxanthin and lipid metabolism: A minireview K Muradian, A Vaiserman, KJ Min, VE Fraifeld Nutrition, Metabolism and Cardiovascular Diseases 25 (10), 891-897, 2015 | 109 | 2015 |
Early-life adversity and long-term neurobehavioral outcomes: epigenome as a bridge? AM Vaiserman, AK Koliada Human genomics 11, 1-15, 2017 | 107 | 2017 |
HDAC inhibitors: A new promising drug class in anti-aging research EG Pasyukova, AM Vaiserman Mechanisms of ageing and development 166, 6-15, 2017 | 104 | 2017 |
Early-life nutritional programming of longevity AM Vaiserman Journal of developmental origins of health and disease 5 (5), 325-338, 2014 | 102 | 2014 |
Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility? A Vaiserman Clinical epigenetics 7, 1-11, 2015 | 96 | 2015 |
Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine AM Vaiserman, B Carstensen, VP Voitenko, MD Tronko, VI Kravchenko, ... Diabetologia 50, 32-35, 2007 | 87 | 2007 |
Insulin-Like Peptides Regulate Feeding Preference and Metabolism in Drosophila UV Semaniuk, DV Gospodaryov, KM Feden'Ko, IS Yurkevych, ... Frontiers in physiology 9, 1083, 2018 | 83 | 2018 |